{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:40:14Z","timestamp":1769827214776,"version":"3.49.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10096-019-03746-1","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T12:46:43Z","timestamp":1576068403000},"page":"613-627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies"],"prefix":"10.1007","volume":"39","author":[{"given":"Hamed","family":"Ebrahimzadeh Leylabadlo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3790-9176","authenticated-orcid":false,"given":"Reza","family":"Ghotaslou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Samadi Kafil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Mehdi","family":"Feizabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Yaghoub","family":"Moaddab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safar","family":"Farajnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Sheykhsaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarvin","family":"Sanaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariush","family":"Shanehbandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Bannazadeh Baghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"issue":"3","key":"3746_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cell.2016.01.013","volume":"164","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R (2016) Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164(3):337\u2013340","journal-title":"Cell"},{"issue":"6","key":"3746_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3109\/03014460.2013.807878","volume":"40","author":"E Bianconi","year":"2013","unstructured":"Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F, Vitale L, Pelleri MC, Tassani S, Piva F (2013) An estimation of the number of cells in the human body. Ann Hum Biol 40(6):463\u2013471","journal-title":"Ann Hum Biol"},{"issue":"6","key":"3746_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/1120009X.2017.1338377","volume":"29","author":"AZ Bialvaei","year":"2017","unstructured":"Bialvaei AZ, Kouhsari E, Salehi-Abargouei A, Amirmozafari N, Ramazanzadeh R, Ghadimi-Daresajini A, Sedighi M (2017) Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis. J Chemother 29(6):327\u2013337","journal-title":"J Chemother"},{"issue":"7","key":"3746_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/sj.embor.7400731","volume":"7","author":"AM O'Hara","year":"2006","unstructured":"O'Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7(7):688\u2013693","journal-title":"EMBO Rep"},{"issue":"10","key":"3746_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/nm.4185","volume":"22","author":"BO Schroeder","year":"2016","unstructured":"Schroeder BO, B\u00e4ckhed F (2016) Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 22(10):1079","journal-title":"Nat Med"},{"key":"3746_CR6","doi-asserted-by":"crossref","unstructured":"Zhi C, Huang J, Wang J, Cao H, Bai Y, Guo J, Su Z (2019) Connection between gut microbiome and the development of obesity. European Journal of Clinical Microbiology & Infectious Diseases:1\u201312","DOI":"10.1007\/s10096-019-03623-x"},{"issue":"4","key":"3746_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrgastro.2010.21","volume":"7","author":"EM Brunt","year":"2010","unstructured":"Brunt EM (2010) Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7(4):195","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"3746_CR8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1478-3231.2006.01323.x","volume":"26","author":"C Day","year":"2006","unstructured":"Day C (2006) Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int 26(9):1021\u20131028","journal-title":"Liver Int"},{"issue":"6","key":"3746_CR9","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1073\/pnas.94.6.2557","volume":"94","author":"SQ Yang","year":"1997","unstructured":"Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci 94(6):2557\u20132562","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"3746_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/gut.48.2.206","volume":"48","author":"A Wigg","year":"2001","unstructured":"Wigg A, Roberts-Thomson I, Dymock R, McCarthy P, Grose R, Cummins A (2001) The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor \u03b1 in the pathogenesis of non-alcoholic steatohepatitis. Gut 48(2):206\u2013211","journal-title":"Gut"},{"issue":"8","key":"3746_CR11","doi-asserted-by":"publisher","first-page":"e12191","DOI":"10.1371\/journal.pone.0012191","volume":"5","author":"S Ding","year":"2010","unstructured":"Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, Jobin C, Lund PK (2010) High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5(8):e12191","journal-title":"PLoS One"},{"issue":"1","key":"3746_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0192623313508481","volume":"42","author":"B Chassaing","year":"2014","unstructured":"Chassaing B, Gewirtz AT (2014) Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol Pathol 42(1):49\u201353","journal-title":"Toxicol Pathol"},{"issue":"5","key":"3746_CR13","first-page":"G413","volume":"312","author":"K Brandl","year":"2017","unstructured":"Brandl K, Kumar V, Eckmann L (2017) Gut-liver axis at the frontier of host-microbial interactions. Am J Physiol-Gastr Liver Physiol 312(5):G413\u2013G419","journal-title":"Am J Physiol-Gastr Liver Physiol"},{"issue":"29","key":"3746_CR14","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.2174\/1381612811319290011","volume":"19","author":"L Miele","year":"2013","unstructured":"Miele L, Marrone G, Lauritano C, Cefalo C, Gasbarrini A, Day C, Grieco A (2013) Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. Curr Pharm Des 19(29):5314\u20135324","journal-title":"Curr Pharm Des"},{"issue":"10","key":"3746_CR15","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/nu10101457","volume":"10","author":"X Meng","year":"2018","unstructured":"Meng X, Li S, Li Y, Gan R-Y, Li H-B (2018) Gut microbiota\u2019s relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics. Nutrients 10(10):1457","journal-title":"Nutrients"},{"key":"3746_CR16","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/srep08096","volume":"5","author":"W Jiang","year":"2015","unstructured":"Jiang W, Wu N, Wang X, Chi Y, Zhang Y, Qiu X, Hu Y, Li J, Liu Y (2015) Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep 5:8096","journal-title":"Sci Rep"},{"issue":"23","key":"3746_CR17","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","volume":"20","author":"K Miura","year":"2014","unstructured":"Miura K, Ohnishi H (2014) Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol: WJG 20(23):7381","journal-title":"World J Gastroenterol: WJG"},{"issue":"6","key":"3746_CR18","first-page":"377","volume":"3","author":"V Bieghs","year":"2014","unstructured":"Bieghs V, Trautwein C (2014) Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr 3(6):377","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"1","key":"3746_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E (2010) Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1\u03b2 in mice. Gastroenterology 139(1):323\u2013334. e327","journal-title":"Gastroenterology"},{"issue":"2","key":"3746_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/hep.26081","volume":"57","author":"K Miura","year":"2013","unstructured":"Miura K, Yang L, van Rooijen N, Brenner DA, Ohnishi H, Seki E (2013) Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 57(2):577\u2013589","journal-title":"Hepatology"},{"issue":"6","key":"3746_CR21","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.jhep.2015.08.001","volume":"63","author":"H-X Liu","year":"2015","unstructured":"Liu H-X, Keane R, Sheng L, Wan Y-JY (2015) Implications of microbiota and bile acid in liver injury and regeneration. J Hepatol 63(6):1502\u20131510","journal-title":"J Hepatol"},{"issue":"1","key":"3746_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T Csak","year":"2011","unstructured":"Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G (2011) Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54(1):133\u2013144","journal-title":"Hepatology"},{"issue":"37","key":"3746_CR23","doi-asserted-by":"publisher","first-page":"15324","DOI":"10.1073\/pnas.1100255108","volume":"108","author":"R Stienstra","year":"2011","unstructured":"Stienstra R, Van Diepen JA, Tack CJ, Zaki MH, Van De Veerdonk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I (2011) Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci 108(37):15324\u201315329","journal-title":"Proc Natl Acad Sci"},{"issue":"7384","key":"3746_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482(7384):179","journal-title":"Nature"},{"issue":"5418","key":"3746_CR25","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B (1999) Identification of a nuclear receptor for bile acids. Science 284(5418):1362\u20131365","journal-title":"Science"},{"issue":"9","key":"3746_CR26","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/apt.13376","volume":"42","author":"A Wieland","year":"2015","unstructured":"Wieland A, Frank D, Harnke B, Bambha K (2015) Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease. Aliment Pharmacol Ther 42(9):1051\u20131063","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"3746_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstr\u00f6m A, Felin J, J\u00e4ntti S, Marschall H-U, Bamberg K, Angelin B, Hy\u00f6tyl\u00e4inen T, Ore\u0161i\u010d M, B\u00e4ckhed F (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17(2):225\u2013235","journal-title":"Cell Metab"},{"issue":"2","key":"3746_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/ijms20020395","volume":"20","author":"I Milosevic","year":"2019","unstructured":"Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A, Gmizic I, Stevanovic O, Djordjevic V, Lekic N (2019) Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. Int J Mol Sci 20(2):395","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3746_CR29","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","volume":"60","author":"BC Ferslew","year":"2015","unstructured":"Ferslew BC, Xie G, Johnston CK, Su M, Stewart PW, Jia W, Brouwer KL, Barritt AS (2015) Altered bile acid metabolome in patients with nonalcoholic steatohepatitis. Dig Dis Sci 60(11):3318\u20133328","journal-title":"Dig Dis Sci"},{"issue":"5","key":"3746_CR30","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","volume":"58","author":"G Kakiyama","year":"2013","unstructured":"Kakiyama G, Pandak WM, Gillevet PM, Hylemon PB, Heuman DM, Daita K, Takei H, Muto A, Nittono H, Ridlon JM (2013) Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol 58(5):949\u2013955","journal-title":"J Hepatol"},{"issue":"1","key":"3746_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","volume":"65","author":"JP Arab","year":"2017","unstructured":"Arab JP, Karpen SJ, Dawson PA, Arrese M, Trauner M (2017) Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Hepatology 65(1):350\u2013362","journal-title":"Hepatology"},{"issue":"1","key":"3746_CR32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1172\/JCI76738","volume":"125","author":"C Jiang","year":"2015","unstructured":"Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang Z-Z, Takahashi S (2015) Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest 125(1):386\u2013402","journal-title":"J Clin Invest"},{"issue":"5","key":"3746_CR33","doi-asserted-by":"publisher","first-page":"e0151829","DOI":"10.1371\/journal.pone.0151829","volume":"11","author":"M Mouzaki","year":"2016","unstructured":"Mouzaki M, Wang AY, Bandsma R, Comelli EM, Arendt BM, Zhang L, Fung S, Fischer SE, McGilvray IG, Allard JP (2016) Bile acids and dysbiosis in non-alcoholic fatty liver disease. PLoS One 11(5):e0151829","journal-title":"PLoS One"},{"issue":"3","key":"3746_CR34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7(3):189\u2013200","journal-title":"Gut Microbes"},{"key":"3746_CR35","doi-asserted-by":"crossref","unstructured":"Canfora EE, Meex RC, Venema K, Blaak EE (2019) Gut microbial metabolites in obesity, NAFLD and T2DM. Nature Reviews Endocrinology 15(5):261\u2013273","DOI":"10.1038\/s41574-019-0156-z"},{"issue":"7122","key":"3746_CR36","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027","journal-title":"Nature"},{"issue":"1","key":"3746_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/oby.2009.167","volume":"18","author":"A Schwiertz","year":"2010","unstructured":"Schwiertz A, Taras D, Sch\u00e4fer K, Beijer S, Bos NA, Donus C, Hardt PD (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18(1):190\u2013195","journal-title":"Obesity"},{"issue":"3","key":"3746_CR38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1017\/S0029665114001700","volume":"74","author":"M Blaut","year":"2015","unstructured":"Blaut M (2015) Gut microbiota and energy balance: role in obesity. Proc Nutr Soc 74(3):227\u2013234","journal-title":"Proc Nutr Soc"},{"issue":"5","key":"3746_CR39","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/jn\/129.5.942","volume":"129","author":"H Hara","year":"1999","unstructured":"Hara H, Haga S, Aoyama Y, Kiriyama S (1999) Short-chain fatty acids suppress cholesterol synthesis in rat liver and intestine. J Nutr 129(5):942\u2013948","journal-title":"J Nutr"},{"issue":"11","key":"3746_CR40","doi-asserted-by":"publisher","first-page":"e80476","DOI":"10.1371\/journal.pone.0080476","volume":"8","author":"G Jakobsdottir","year":"2013","unstructured":"Jakobsdottir G, Xu J, Molin G, Ahrne S, Nyman M (2013) High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS One 8(11):e80476","journal-title":"PLoS One"},{"issue":"7268","key":"3746_CR41","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461(7268):1282\u20131286","journal-title":"Nature"},{"issue":"3","key":"3746_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4161\/gmic.29330","volume":"5","author":"MB Geuking","year":"2014","unstructured":"Geuking MB, K\u00f6ller Y, Rupp S, McCoy KD (2014) The interplay between the gut microbiota and the immune system. Gut Microbes 5(3):411\u2013418","journal-title":"Gut Microbes"},{"issue":"4","key":"3746_CR43","doi-asserted-by":"publisher","first-page":"e35240","DOI":"10.1371\/journal.pone.0035240","volume":"7","author":"HV Lin","year":"2012","unstructured":"Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G (2012) Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 7(4):e35240","journal-title":"PLoS One"},{"issue":"6","key":"3746_CR44","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2010.09.032","volume":"54","author":"S Ben-Shlomo","year":"2011","unstructured":"Ben-Shlomo S, Zvibel I, Shnell M, Shlomai A, Chepurko E, Halpern Z, Barzilai N, Oren R, Fishman S (2011) Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol 54(6):1214\u20131223","journal-title":"J Hepatol"},{"key":"3746_CR45","doi-asserted-by":"crossref","unstructured":"Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D (2011) Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver Int 31(9):1285\u20131297","DOI":"10.1111\/j.1478-3231.2011.02462.x"},{"issue":"7","key":"3746_CR46","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.2337\/dc14-2548","volume":"38","author":"A Tang","year":"2015","unstructured":"Tang A, Rabasa-Lhoret R, Castel H, Wartelle-Bladou C, Gilbert G, Massicotte-Tisluck K, Chartrand G, Olivi\u00e9 D, Julien A-S, de Guise J (2015) Effects of insulin glargine and liraglutide therapy on liver fat as measured by magnetic resonance in patients with type 2 diabetes: a randomized trial. Diabetes Care 38(7):1339\u20131346","journal-title":"Diabetes Care"},{"key":"3746_CR47","doi-asserted-by":"crossref","unstructured":"Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L (2014) The role of short-chain fatty acids in health and disease. Advances in immunology. Elsevier, pp 91\u2013119","DOI":"10.1016\/B978-0-12-800100-4.00003-9"},{"issue":"10","key":"3746_CR48","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1177\/2050640618804444","volume":"6","author":"M Rau","year":"2018","unstructured":"Rau M, Rehman A, Dittrich M, Groen AK, Hermanns HM, Seyfried F, Beyersdorf N, Dandekar T, Rosenstiel P, Geier A (2018) Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease. United European Gastroenterol J 6(10):1496\u20131507","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"3746_CR49","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v23.i1.60","volume":"23","author":"D Zhou","year":"2017","unstructured":"Zhou D, Qin Pan F-ZX, Zhang R-N, He C-X, Chen G-Y, Liu C, Chen Y-W, Fan J-G (2017) Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. World J Gastroenterol 23(1):60","journal-title":"World J Gastroenterol"},{"issue":"9","key":"3746_CR50","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/jgh.13742","volume":"32","author":"D Zhou","year":"2017","unstructured":"Zhou D, Pan Q, Liu XL, Yang RX, Chen YW, Liu C, Fan JG (2017) Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation. J Gastroenterol Hepatol 32(9):1640\u20131648","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"3746_CR51","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1007\/s10620-012-2112-9","volume":"57","author":"V Volynets","year":"2012","unstructured":"Volynets V, K\u00fcper MA, Strahl S, Maier IB, Spruss A, Wagnerberger S, K\u00f6nigsrainer A, Bischoff SC, Bergheim I (2012) Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 57(7):1932\u20131941","journal-title":"Dig Dis Sci"},{"issue":"2","key":"3746_CR52","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","volume":"28","author":"KD Corbin","year":"2012","unstructured":"Corbin KD, Zeisel SH (2012) Choline metabolism provides novel insights into non-alcoholic fatty liver disease and its progression. Curr Opin Gastroenterol 28(2):159","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"3746_CR53","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","volume":"11","author":"AA Kolodziejczyk","year":"2019","unstructured":"Kolodziejczyk AA, Zheng D, Shibolet O, Elinav E (2019) The role of the microbiome in NAFLD and NASH. EMBO Mol Med 11(2):e9302","journal-title":"EMBO Mol Med"},{"issue":"3","key":"3746_CR54","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","volume":"140","author":"MD Spencer","year":"2011","unstructured":"Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA (2011) Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 140(3):976\u2013986","journal-title":"Gastroenterology"},{"issue":"12","key":"3746_CR55","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1017\/S0007114511004983","volume":"107","author":"S Wagnerberger","year":"2012","unstructured":"Wagnerberger S, Spruss A, Kanuri G, Volynets V, Stahl C, Bischoff SC, Bergheim I (2012) Toll-like receptors 1\u20139 are elevated in livers with fructose-induced hepatic steatosis. Br J Nutr 107(12):1727\u20131738","journal-title":"Br J Nutr"},{"issue":"1","key":"3746_CR56","doi-asserted-by":"publisher","first-page":"e0170742","DOI":"10.1371\/journal.pone.0170742","volume":"12","author":"W Stremmel","year":"2017","unstructured":"Stremmel W, Schmidt KV, Schuhmann V, Kratzer F, Garbade SF, Langhans C-D, Fricker G, Okun JG (2017) Blood trimethylamine-N-oxide originates from microbiota mediated breakdown of phosphatidylcholine and absorption from small intestine. PLoS One 12(1):e0170742","journal-title":"PLoS One"},{"key":"3746_CR57","first-page":"210","volume":"24","author":"D Ackermann","year":"1910","unstructured":"Ackermann D, Schutze H (1910) The formation of trimethylamine by bacterium prodigiosum. Zentralb Physiol 24:210\u2013211","journal-title":"Zentralb Physiol"},{"issue":"7341","key":"3746_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, Feldstein AE, Britt EB, Fu X, Chung Y-M (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57","journal-title":"Nature"},{"issue":"3","key":"3746_CR59","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WW Tang","year":"2015","unstructured":"Tang WW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL (2015) Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 116(3):448\u2013455","journal-title":"Circ Res"},{"issue":"33","key":"3746_CR60","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.1073\/pnas.0601056103","volume":"103","author":"M-E Dumas","year":"2006","unstructured":"Dumas M-E, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci 103(33):12511\u201312516","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"3746_CR61","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19(5):576","journal-title":"Nat Med"},{"issue":"12","key":"3746_CR62","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/nu10121971","volume":"10","author":"L Barrea","year":"2018","unstructured":"Barrea L, Annunziata G, Muscogiuri G, Di Somma C, Laudisio D, Maisto M, de Alteriis G, Tenore G, Colao A, Savastano S (2018) Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients 10(12):1971","journal-title":"Nutrients"},{"issue":"3","key":"3746_CR63","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00005176-200303000-00026","volume":"36","author":"B Logan","year":"2003","unstructured":"Logan B, Jones AW (2003) Endogenous ethanol production in a child with short gut syndrome. J Pediatr Gastroenterol Nutr 36(3):419\u2013420","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"3746_CR64","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/gast.2000.19267","volume":"119","author":"K Cope","year":"2000","unstructured":"Cope K, Risby T, Diehl AM (2000) Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119(5):1340\u20131347","journal-title":"Gastroenterology"},{"issue":"4","key":"3746_CR65","doi-asserted-by":"publisher","first-page":"A972","DOI":"10.1016\/S0016-5085(00)86032-1","volume":"118","author":"S Nair","year":"2000","unstructured":"Nair S, Cope K, Risby T (2000) Obesity and female gender increase breath ethanol: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Gastroenterology 118(4):A972","journal-title":"Gastroenterology"},{"issue":"2","key":"3746_CR66","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57(2):601\u2013609","journal-title":"Hepatology"},{"issue":"4","key":"3746_CR67","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/j.1572-0241.2001.03702.x","volume":"96","author":"S Nair","year":"2001","unstructured":"Nair S, Cope K, Terence RH, Diehl AM (2001) Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 96(4):1200\u20131204","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"3746_CR68","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/gutjnl-2016-311571","volume":"65","author":"L Zhu","year":"2016","unstructured":"Zhu L, Baker RD, Zhu R, Baker SS (2016) Gut microbiota produce alcohol and contribute to NAFLD. Gut 65(7):1232\u20131232","journal-title":"Gut"},{"issue":"1","key":"3746_CR69","doi-asserted-by":"publisher","first-page":"1600240","DOI":"10.1002\/mnfr.201600240","volume":"61","author":"B S\u00e1nchez","year":"2017","unstructured":"S\u00e1nchez B, Delgado S, Blanco-M\u00edguez A, Louren\u00e7o A, Gueimonde M, Margolles A (2017) Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res 61(1):1600240","journal-title":"Mol Nutr Food Res"},{"key":"3746_CR70","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","volume":"15","author":"A Borrelli","year":"2018","unstructured":"Borrelli A, Bonelli P, Tuccillo FM, Goldfine ID, Evans JL, Buonaguro FM, Mancini A (2018) Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches. Redox Biol 15:467\u2013479","journal-title":"Redox Biol"},{"issue":"1","key":"3746_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ismej.2014.99","volume":"9","author":"J Wang","year":"2015","unstructured":"Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, Vlieg JE-H, Strissel K, Zhao L, Obin M (2015) Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 9(1):1","journal-title":"ISME J"},{"key":"3746_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.copbio.2014.10.006","volume":"32","author":"PD Cani","year":"2015","unstructured":"Cani PD, Van Hul M (2015) Novel opportunities for next-generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol 32:21\u201327","journal-title":"Curr Opin Biotechnol"},{"issue":"1\u20132","key":"3746_CR73","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/pr.2014.157","volume":"77","author":"L Zhu","year":"2015","unstructured":"Zhu L, Baker RD, Baker SS (2015) Gut microbiome and nonalcoholic fatty liver diseases. Pediatr Res 77(1\u20132):245","journal-title":"Pediatr Res"},{"issue":"6","key":"3746_CR74","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/hep.510260621","volume":"26","author":"Y Iimuro","year":"1997","unstructured":"Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG (1997) Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 26(6):1530\u20131537","journal-title":"Hepatology"},{"issue":"5","key":"3746_CR75","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3945\/jn.108.101808","volume":"139","author":"E Esposito","year":"2009","unstructured":"Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P, Canani RB, Calignano A, Raso GM, Meli R (2009) Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr 139(5):905\u2013911","journal-title":"J Nutr"},{"issue":"2","key":"3746_CR76","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/jhep.2003.50048","volume":"37","author":"Z Li","year":"2003","unstructured":"Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, DeSimone C, Xy S, Diehl AM (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37(2):343\u2013350","journal-title":"Hepatology"},{"issue":"8","key":"3746_CR77","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jnutbio.2010.10.002","volume":"22","author":"A Iacono","year":"2011","unstructured":"Iacono A, Raso GM, Canani RB, Calignano A, Meli R (2011) Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem 22(8):699\u2013711","journal-title":"J Nutr Biochem"},{"issue":"52","key":"3746_CR78","doi-asserted-by":"publisher","first-page":"21307","DOI":"10.1073\/pnas.1215689109","volume":"109","author":"S Craciun","year":"2012","unstructured":"Craciun S, Balskus EP (2012) Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci 109(52):21307\u201321312","journal-title":"Proc Natl Acad Sci"},{"key":"3746_CR79","doi-asserted-by":"crossref","unstructured":"Kobyliak N, Abenavoli L, Mykhalchyshyn G, Kononenko L, Boccuto L, Kyriienko D, Dynnyk O (2018) A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial. J Gastrointestin Liver Dis 27(1):41\u201349","DOI":"10.15403\/jgld.2014.1121.271.kby"},{"key":"3746_CR80","doi-asserted-by":"crossref","unstructured":"Manzhalii E, Virchenko O, Falalyeyeva T, Beregova T, Stremmel W (2017) Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: a pilot trial. J Dig Dis 18(12):698\u2013703","DOI":"10.1111\/1751-2980.12561"},{"key":"3746_CR81","doi-asserted-by":"crossref","unstructured":"Lirussi F, Mastropasqua E, Orando S, Orlando R (2007) Probiotics for non-alcoholic fatty liver disease and\/or steatohepatitis. Cochrane database of systematic reviews 24(1):CD005165","DOI":"10.1002\/14651858.CD005165.pub2"},{"issue":"6","key":"3746_CR82","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","volume":"39","author":"C Loguercio","year":"2005","unstructured":"Loguercio C, Federico A, Tuccillo C, Terracciano F, D'auria MV, De Simone C, Blanco CDV (2005) Beneficial effects of a probiotic VSL# 3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol 39(6):540\u2013543","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"3746_CR83","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/MPG.0b013e31821f9b85","volume":"52","author":"P Vajro","year":"2011","unstructured":"Vajro P, Mandato C, Licenziati MR, Franzese A, Vitale DF, Lenta S, Caropreso M, Vallone G, Meli R (2011) Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J Pediatr Gastroenterol Nutr 52(6):740\u2013743","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"3746_CR84","first-page":"1090","volume":"15","author":"R Aller","year":"2011","unstructured":"Aller R, De Luis D, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, De La Fuente B, Gonzalez J (2011) Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 15(9):1090\u20131095","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"3746_CR85","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1038\/s41598-019-42059-3","volume":"9","author":"SB Ahn","year":"2019","unstructured":"Ahn SB, Jun DW, Kang B-K, Lim JH, Lim S, Chung M-J (2019) Randomized, double-blind, placebo-controlled study of a multispecies probiotic mixture in nonalcoholic fatty liver disease. Sci Rep 9(1):5688","journal-title":"Sci Rep"},{"issue":"11","key":"3746_CR86","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/nutrit\/nuy031","volume":"76","author":"BR Loman","year":"2018","unstructured":"Loman BR, Hern\u00e1ndez-Saavedra D, An R, Rector RS (2018) Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutr Rev 76(11):822\u2013839","journal-title":"Nutr Rev"},{"issue":"8","key":"3746_CR87","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD (2017) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 14(8):491","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"3746_CR88","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/mnfr.200500015","volume":"49","author":"CC Lim","year":"2005","unstructured":"Lim CC, Ferguson LR, Tannock GW (2005) Dietary fibres as \u201cprebiotics\u201d: implications for colorectal cancer. Mol Nutr Food Res 49(6):609\u2013619","journal-title":"Mol Nutr Food Res"},{"key":"3746_CR89","first-page":"183","volume":"172","author":"F Petuely","year":"1949","unstructured":"Petuely F, Kristen G (1949) Changing the intestinal flora of infants.(Short preliminary communication.). Ann Paediatr 172:183\u2013184","journal-title":"Ann Paediatr"},{"issue":"5","key":"3746_CR90","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/sj.ejcn.1602127","volume":"59","author":"C Daubioul","year":"2005","unstructured":"Daubioul C, Horsmans Y, Lambert P, Danse E, Delzenne NM (2005) Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr 59(5):723","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"3746_CR91","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.pharmthera.2011.01.012","volume":"130","author":"PD Cani","year":"2011","unstructured":"Cani PD, Delzenne NM (2011) The gut microbiome as therapeutic target. Pharmacol Ther 130(2):202\u2013212","journal-title":"Pharmacol Ther"},{"issue":"32","key":"3746_CR92","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.3748\/wjg.v11.i32.5053","volume":"11","author":"J-G Fan","year":"2005","unstructured":"Fan J-G, Xu Z-J, Wang G-L (2005) Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model. World J Gastroenterol: WJG 11(32):5053","journal-title":"World J Gastroenterol: WJG"},{"issue":"3","key":"3746_CR93","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ijo.2015.197","volume":"40","author":"DP Singh","year":"2016","unstructured":"Singh DP, Khare P, Zhu J, Kondepudi KK, Singh J, Baboota RK, Boparai RK, Khardori R, Chopra K, Bishnoi M (2016) A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice. Int J Obes 40(3):487\u2013496","journal-title":"Int J Obes"},{"issue":"1","key":"3746_CR94","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/09637486.2016.1212819","volume":"68","author":"A Micka","year":"2017","unstructured":"Micka A, Siepelmeyer A, Holz A, Theis S, Sch\u00f6n C (2017) Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: a randomized, double-blind, placebo-controlled trial. Int J Food Sci Nutr 68(1):82\u201389","journal-title":"Int J Food Sci Nutr"},{"issue":"7","key":"3746_CR95","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1017\/S0007114513003607","volume":"111","author":"NJ Kellow","year":"2014","unstructured":"Kellow NJ, Coughlan MT, Reid CM (2014) Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. Br J Nutr 111(7):1147\u20131161","journal-title":"Br J Nutr"},{"issue":"6","key":"3746_CR96","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3945\/ajcn.2009.27465","volume":"89","author":"JA Parnell","year":"2009","unstructured":"Parnell JA, Reimer RA (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89(6):1751\u20131759","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"3746_CR97","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00394-018-1721-2","volume":"58","author":"MR Bomhof","year":"2019","unstructured":"Bomhof MR, Parnell JA, Ramay HR, Crotty P, Rioux KP, Probert CS, Jayakumar S, Raman M, Reimer RA (2019) Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial. Eur J Nutr 58(4):1735\u20131745","journal-title":"Eur J Nutr"},{"issue":"40","key":"3746_CR98","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.3748\/wjg.v19.i40.6911","volume":"19","author":"Y-Y Ma","year":"2013","unstructured":"Ma Y-Y, Li L, Yu C-H, Shen Z, Chen L-H, Li Y-M (2013) Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol: WJG 19(40):6911","journal-title":"World J Gastroenterol: WJG"},{"issue":"5","key":"3746_CR99","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E Van Nood","year":"2013","unstructured":"Van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368(5):407\u2013415","journal-title":"N Engl J Med"},{"issue":"11","key":"3746_CR100","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/ajg.2012.251","volume":"107","author":"F Zhang","year":"2012","unstructured":"Zhang F, Luo W, Shi Y, Fan Z, Ji G (2012) Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol 107(11):1755","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3746_CR101","first-page":"854","volume":"44","author":"\u00c1 Eiseman","year":"1958","unstructured":"Eiseman \u00c1, Silen W, Bascom G, Kauvar A (1958) Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44(5):854\u2013859","journal-title":"Surgery"},{"issue":"4","key":"3746_CR102","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ajg.2013.4","volume":"108","author":"CM Surawicz","year":"2013","unstructured":"Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108(4):478","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"3746_CR103","first-page":"483","volume":"66","author":"P Konturek","year":"2015","unstructured":"Konturek P, Haziri D, Brzozowski T, Hess T, Heyman S, Kwiecien S, Konturek S, Koziel J (2015) Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases. J Physiol Pharmacol 66(4):483\u2013491","journal-title":"J Physiol Pharmacol"},{"issue":"1","key":"3746_CR104","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3748\/wjg.v21.i1.102","volume":"21","author":"M-Q Xu","year":"2015","unstructured":"Xu M-Q, Cao H-L, Wang W-Q, Wang S, Cao X-C, Yan F, Wang B-M (2015) Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol: WJG 21(1):102","journal-title":"World J Gastroenterol: WJG"},{"key":"3746_CR105","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze A (2012) Vrieze A, Van Nood E, Holleman F, Saloj\u00e4rvi J, Kootte RS, Bartelsman JF, et al. Metabolic effects of transplanting gut microbiota from lean donors to subjects with metabolic syndrome. Gastroenterology 143:913\u2013916","journal-title":"Gastroenterology"},{"issue":"12","key":"3746_CR106","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","volume":"62","author":"T Le Roy","year":"2013","unstructured":"Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, Martin P, Philippe C, Walker F, Bado A (2013) Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62(12):1787\u20131794","journal-title":"Gut"},{"issue":"5","key":"3746_CR107","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly CJ, Zheng L, Campbell EL, Saeedi B, Scholz CC, Bayless AJ, Wilson KE, Glover LE, Kominsky DJ, Magnuson A (2015) Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17(5):662\u2013671","journal-title":"Cell Host Microbe"},{"issue":"1","key":"3746_CR108","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","volume":"7","author":"D Zhou","year":"2017","unstructured":"Zhou D, Pan Q, Shen F, H-x C, W-j D, Y-w C, J-g F (2017) Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. Sci Rep 7(1):1529","journal-title":"Sci Rep"},{"issue":"4","key":"3746_CR109","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","volume":"15","author":"CA Philips","year":"2017","unstructured":"Philips CA, Pande A, Shasthry SM, Jamwal KD, Khillan V, Chandel SS, Kumar G, Sharma MK, Maiwall R, Jindal A (2017) Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study. Clin Gastroenterol Hepatol 15(4):600\u2013602","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"3746_CR110","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1093\/cid\/civ646","volume":"61","author":"HE Leylabadlo","year":"2015","unstructured":"Leylabadlo HE, Bialvaei AZ, Samadi Kafil H (2015) Brucellosis in Iran: why not eradicated? Clin Infect Dis 61(10):1629\u20131630","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3746_CR111","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s10620-017-4535-9","volume":"62","author":"NA Cohen","year":"2017","unstructured":"Cohen NA, Maharshak N (2017) Novel indications for fecal microbial transplantation: update and review of the literature. Dig Dis Sci 62(5):1131\u20131145","journal-title":"Dig Dis Sci"},{"key":"3746_CR112","doi-asserted-by":"publisher","first-page":"32002","DOI":"10.1038\/srep32002","volume":"6","author":"B Wang","year":"2016","unstructured":"Wang B, Jiang X, Cao M, Ge J, Bao Q, Tang L, Chen Y, Li L (2016) Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease. Sci Rep 6:32002","journal-title":"Sci Rep"},{"key":"3746_CR113","doi-asserted-by":"crossref","unstructured":"Nistal E, S\u00e1enz-de-Miera LE, Ballesteros Pomar M, S\u00e1nchez-Campos S, Garc\u00eda-Mediavilla MV, \u00c1lvarez-Cuenllas B, Linares P, Olcoz JL, Arias-Loste MT, Garc\u00eda-Lobo JM (2019) An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity. Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva 111","DOI":"10.17235\/reed.2019.6068\/2018"},{"issue":"1","key":"3746_CR114","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hep.26319","volume":"58","author":"M Mouzaki","year":"2013","unstructured":"Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, McGilvray ID, Allard JP (2013) Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 58(1):120\u2013127","journal-title":"Hepatology"},{"issue":"5","key":"3746_CR115","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5152\/tjg.2017.17033","volume":"28","author":"C \u00d6zkul","year":"2017","unstructured":"\u00d6zkul C, Yal\u0131nay M, Karakan T, Y\u0131lmaz G (2017) Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis. Turk J Gastroenterol 28(5):361\u2013369","journal-title":"Turk J Gastroenterol"},{"key":"3746_CR116","doi-asserted-by":"crossref","unstructured":"Sobhonslidsuk A, Chanprasertyothin S, Pongrujikorn T, Kaewduang P, Promson K, Petraksa S, Ongphiphadhanakul B (2018) The association of gut microbiota with nonalcoholic Steatohepatitis in Thais. Biomed Res Int 2018:9340316","DOI":"10.1155\/2018\/9340316"},{"key":"3746_CR117","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature11552","volume":"489","author":"V Tremaroli","year":"2012","unstructured":"Tremaroli V, B\u00e4ckhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489:242","journal-title":"Nature"},{"issue":"2","key":"3746_CR118","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.28572","volume":"65","author":"F Del Chierico","year":"2017","unstructured":"Del Chierico F, Nobili V, Vernocchi P, Russo A, Stefanis CD, Gnani D, Furlanello C, Zandon\u00e0 A, Paci P, Capuani G (2017) Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. Hepatology 65(2):451\u2013464","journal-title":"Hepatology"},{"issue":"7","key":"3746_CR119","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","volume":"11","author":"M Raman","year":"2013","unstructured":"Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P (2013) Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 11(7):868\u2013875. e863","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"3746_CR120","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s11427-017-9303-9","volume":"61","author":"F Li","year":"2018","unstructured":"Li F, Sun G, Wang Z, Wu W, Guo H, Peng L, Wu L, Guo X, Yang Y (2018) Characteristics of fecal microbiota in non-alcoholic fatty liver disease patients. Sci China Life Sci 61(7):770\u2013778","journal-title":"Sci China Life Sci"},{"issue":"11","key":"3746_CR121","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/apt.12758","volume":"39","author":"A Alisi","year":"2014","unstructured":"Alisi A, Bedogni G, Baviera G, Giorgio V, Porro E, Paris C, Giammaria P, Reali L, Anania F, Nobili V (2014) Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non-alcoholic steatohepatitis. Aliment Pharmacol Ther 39(11):1276\u20131285","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3746_CR122","doi-asserted-by":"publisher","first-page":"e62885","DOI":"10.1371\/journal.pone.0062885","volume":"8","author":"VW-S Wong","year":"2013","unstructured":"Wong VW-S, Tse C-H, Lam TT-Y, Wong GL-H, Chim AM-L, Chu WC-W, Yeung DK-W, Law PT-W, Kwan H-S, Yu J (2013) Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis\u2013a longitudinal study. PLoS One 8(4):e62885","journal-title":"PLoS One"},{"issue":"6","key":"3746_CR123","doi-asserted-by":"publisher","first-page":"418","DOI":"10.23736\/S0026-4806.18.05845-7","volume":"109","author":"N Kobyliak","year":"2018","unstructured":"Kobyliak N, Abenavoli L, Falalyeyeva T, Mykhalchyshyn G, Boccuto L, Kononenko L, Kyriienko D, Komisarenko I, Dynnyk O (2018) Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study. Minerva Med 109(6):418\u2013428","journal-title":"Minerva Med"},{"issue":"2","key":"3746_CR124","first-page":"101","volume":"57","author":"W Wang","year":"2018","unstructured":"Wang W, Shi LP, Shi L, Xu L (2018) Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease. Zhonghua nei ke za zhi 57(2):101\u2013106","journal-title":"Zhonghua nei ke za zhi"},{"key":"3746_CR125","doi-asserted-by":"crossref","unstructured":"Manzhalii E, Virchenko O, Falalyeyeva T, Beregova T, Stremmel W (2017) Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial. Journal of digestive diseases 18(12):698\u2013703","DOI":"10.1111\/1751-2980.12561"},{"issue":"3","key":"3746_CR126","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MPG.0000000000001422","volume":"64","author":"F Famouri","year":"2017","unstructured":"Famouri F, Shariat Z, Hashemipour M, Keikha M, Kelishadi R (2017) Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents. J Pediatr Gastroenterol Nutr 64(3):413\u2013417","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"3746_CR127","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1080\/07315724.2015.1031355","volume":"35","author":"A Sepideh","year":"2016","unstructured":"Sepideh A, Karim P, Hossein A, Leila R, Hamdollah M, Mohammad EG, Mojtaba S, Mohammad S, Ghader G, Seyed Moayed A (2016) Effects of multistrain probiotic supplementation on glycemic and inflammatory indices in patients with nonalcoholic fatty liver disease: a double-blind randomized clinical trial. J Am Coll Nutr 35(6):500\u2013505","journal-title":"J Am Coll Nutr"},{"issue":"12","key":"3746_CR128","doi-asserted-by":"publisher","first-page":"7386","DOI":"10.3168\/jds.2014-8500","volume":"97","author":"S Nabavi","year":"2014","unstructured":"Nabavi S, Rafraf M, Somi M, Homayouni-Rad A, Asghari-Jafarabadi M (2014) Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J Dairy Sci 97(12):7386\u20137393","journal-title":"J Dairy Sci"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03746-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03746-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03746-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T01:24:56Z","timestamp":1607563496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03746-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3746"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03746-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"18 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is not necessary, since this is a review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This is not necessary, since this is a review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}